Aeglea Biotherapeutics Uk Limited is a private limited company registered at Oak House, Tanshire Park, Shackleford Road, Elstead GU8 6LB. Incorporated on 2019-11-14, this 4-year-old company is run by 2 directors.
Director Scott B., appointed on 01 September 2023. Director Heidy K., appointed on 01 September 2023.
The company is classified as "research and experimental development on biotechnology" (SIC code: 72110).
The last confirmation statement was filed on 2022-10-20 and the deadline for the following filing is 2023-11-03. Furthermore, the accounts were filed on 31 December 2021 and the next filing is due on 30 September 2023.
| Office Address | Oak House, Tanshire Park |
| Office Address2 | Shackleford Road |
| Town | Elstead |
| Post code | GU8 6LB |
| Country of origin | United Kingdom |
| Registration Number | 12314872 |
| Date of Incorporation | Thu, 14th Nov 2019 |
| Industry | Research and experimental development on biotechnology |
| End of financial Year | 31st December |
| Company age | 5 years old |
| Account next due date | Sat, 30th Sep 2023 (207 days after) |
| Account last made up date | Fri, 31st Dec 2021 |
| Next confirmation statement due date | Fri, 3rd Nov 2023 (2023-11-03) |
| Last confirmation statement dated | Thu, 20th Oct 2022 |
Position: Director
Appointed: 01 September 2023
Position: Director
Appointed: 01 September 2023
Position: Corporate Secretary
Appointed: 14 November 2019
The register of persons with significant control who own or control the company includes 1 name. As we found, there is Spyre Therapeutics, Inc. from Waltham, United States. This PSC is categorised as "a corporation", has 75,01-100% voting rights and has 75,01-100% shares. This PSC has 75,01-100% voting rights and has 75,01-100% shares.
Spyre Therapeutics, Inc.
221 Crescent Street, Building 23, Suite 105, Waltham, Massachusetts, 02453, United States
| Legal authority | Delaware |
| Legal form | Corporation |
| Country registered | United States |
| Place registered | Delaware |
| Registration number | 5449581 |
| Notified on | 14 November 2019 |
| Nature of control: |
75,01-100% shares 75,01-100% voting rights right to appoint and remove directors |
| Type | Category | Free download | |
|---|---|---|---|
| CS01 |
Confirmation statement with updates October 20, 2023 filed on: 14th, November 2023 |
confirmation statement | Free Download (5 pages) |
© bizstats.co.uk 2024.
Terms of Use and Privacy Policy